LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SK-BR-3 | XMD16-144 | 0.12 | uM | LJP5 | 3 | M11 | 72 | hr | 1476 | 1422 | 3694 | 0.3849 | -0.0247 |
SK-BR-3 | Brivanib | 0.12 | uM | LJP5 | 1 | P17 | 72 | hr | 1476 | 2993 | 3694 | 0.8102 | 0.6838 |
SK-BR-3 | Brivanib | 0.12 | uM | LJP5 | 2 | P17 | 72 | hr | 1476 | 2907 | 3694 | 0.7869 | 0.6451 |
SK-BR-3 | Brivanib | 0.12 | uM | LJP5 | 3 | P17 | 72 | hr | 1476 | 2838 | 3694 | 0.7683 | 0.6139 |
SK-BR-3 | Buparlisib | 0.12 | uM | LJP5 | 1 | H05 | 72 | hr | 1476 | 3019 | 3694 | 0.8173 | 0.6956 |
SK-BR-3 | Buparlisib | 0.12 | uM | LJP5 | 2 | H05 | 72 | hr | 1476 | 3024 | 3694 | 0.8186 | 0.6978 |
SK-BR-3 | Buparlisib | 0.12 | uM | LJP5 | 3 | H05 | 72 | hr | 1476 | 3128 | 3694 | 0.8468 | 0.7447 |
SK-BR-3 | BX-912 | 0.12 | uM | LJP5 | 1 | L23 | 72 | hr | 1476 | 3121 | 3694 | 0.8449 | 0.7416 |
SK-BR-3 | BX-912 | 0.12 | uM | LJP5 | 2 | L23 | 72 | hr | 1476 | 2920 | 3694 | 0.7905 | 0.6509 |
SK-BR-3 | BX-912 | 0.12 | uM | LJP5 | 3 | L23 | 72 | hr | 1476 | 2942 | 3694 | 0.7964 | 0.6608 |
SK-BR-3 | Canertinib | 0.12 | uM | LJP6 | 1 | H11 | 72 | hr | 1476 | 1548 | 3694 | 0.4191 | 0.0321 |
SK-BR-3 | Canertinib | 0.12 | uM | LJP6 | 2 | H11 | 72 | hr | 1476 | 1596 | 3694 | 0.4321 | 0.0538 |
SK-BR-3 | Canertinib | 0.12 | uM | LJP6 | 3 | H11 | 72 | hr | 1476 | 1551 | 3694 | 0.4199 | 0.0335 |
SK-BR-3 | Celastrol | 0.12 | uM | LJP6 | 1 | G11 | 72 | hr | 1476 | 2644 | 3694 | 0.7158 | 0.5264 |
SK-BR-3 | Celastrol | 0.12 | uM | LJP6 | 2 | G11 | 72 | hr | 1476 | 2842 | 3694 | 0.7694 | 0.6157 |
SK-BR-3 | Celastrol | 0.12 | uM | LJP6 | 3 | G11 | 72 | hr | 1476 | 3161 | 3694 | 0.8557 | 0.7596 |
SK-BR-3 | CGP60474 | 0.12 | uM | LJP5 | 1 | F05 | 72 | hr | 1476 | 2022 | 3694 | 0.5474 | 0.2459 |
SK-BR-3 | CGP60474 | 0.12 | uM | LJP5 | 2 | F05 | 72 | hr | 1476 | 2014 | 3694 | 0.5452 | 0.2423 |
SK-BR-3 | CGP60474 | 0.12 | uM | LJP5 | 3 | F05 | 72 | hr | 1476 | 2087 | 3694 | 0.5650 | 0.2752 |
SK-BR-3 | CGP60474 | 0.12 | uM | LJP6 | 1 | G05 | 72 | hr | 1476 | 997 | 3694 | 0.2699 | -0.2164 |
SK-BR-3 | CGP60474 | 0.12 | uM | LJP6 | 2 | G05 | 72 | hr | 1476 | 977 | 3694 | 0.2645 | -0.2254 |
SK-BR-3 | CGP60474 | 0.12 | uM | LJP6 | 3 | G05 | 72 | hr | 1476 | 780 | 3694 | 0.2112 | -0.3142 |
SK-BR-3 | CHIR-99021 | 0.12 | uM | LJP6 | 1 | P17 | 72 | hr | 1476 | 2979 | 3694 | 0.8064 | 0.6775 |
SK-BR-3 | CHIR-99021 | 0.12 | uM | LJP6 | 2 | P17 | 72 | hr | 1476 | 2757 | 3694 | 0.7463 | 0.5774 |
SK-BR-3 | CHIR-99021 | 0.12 | uM | LJP6 | 3 | P17 | 72 | hr | 1476 | 2688 | 3694 | 0.7277 | 0.5463 |